A Randomized Study Comparing Two Intermittent Dosing Schedules of Duvelisib In Subjects with Indolent NonHodgkins Lymphoma (VS-0145-229)
A Randomized Study Comparing Two Intermittent Dosing Schedules of Duvelisib In Subjects with Indolent NonHodgkins Lymphoma (VS-0145-229)
Trial Category:
Lymphoma
Phase
II
Contact(s)
Location(s)
Nebraska Cancer Specialists, Omaha, NE